Neurological & CognitiveLimited ResearchResearch OnlyB

DSIP

Delta Sleep-Inducing Peptide · Proposed modulation of delta-wave sleep via thalamic and hypothalamic mechanisms; interaction with sigma receptors and opioid pathways; reduction of ACTH and LH secretion; antioxidant properties via lipid peroxidation inhibition

Last reviewed . First published . By the PeptIQ team.

Educational and observational reference only. Not medical advice. Community charts may use modeled aggregates when live snapshots are unavailable.

Studies cited
6
Research grade
B
Experience
73

Overall check-ins

Activity
62

Trackers & reports

Typical Dose

25–100 mcg (research; no established human dose)

Route

Injectable

Cycle

Protocol-dependent

Storage

2–8°C Refrigerated

What is DSIP?

Delta sleep-inducing peptide (DSIP) is a nonapeptide first isolated in 1977 from thalamic perfusate of sleeping rabbits by Monnier et al. that induced slow-wave (delta) sleep when infused. Subsequent research has explored roles in pain modulation, stress response, temperature regulation, and antioxidant effects. Clinical evidence is limited and inconsistent; mechanism remains poorly characterized. Research only.

Mechanism of Action

Proposed modulation of delta-wave sleep via thalamic and hypothalamic mechanisms; interaction with sigma receptors and opioid pathways; reduction of ACTH and LH secretion; antioxidant properties via lipid peroxidation inhibition

Target: Sigma receptors, hypothalamic-pituitary axis, thalamic sleep centers

Research Indications

Cognitive FunctionEffective

Research suggests improvements in memory, focus, and cognitive processing

NeuroprotectionModerate

May protect neurons from oxidative stress and inflammatory damage

Mood & AnxietyModerate

Some studies report anxiolytic and mood-stabilizing effects

Research Protocols

These are commonly discussed research protocols — not medical advice. Consult a healthcare provider before use.

GoalDoseFrequencyRoute
Starting DoseLow doseOnce dailyIntranasal or Injectable
Standard DoseStandardOnce dailyIntranasal or Injectable

Peptide & Drug Interactions

Always consult your healthcare provider before combining with other compounds. Use our Interaction Checker for reference.

Stimulants (Modafinil, Adderall)Caution
MAOIs / SSRIsMonitor
RacetamsCaution
NAD+Compatible
BPC-157Compatible

How to Reconstitute & Inject

Use bacteriostatic (BAC) water only. Avoid saline — may cause precipitation. Refrigerate and use within 28 days.

  1. 1

    Remove DSIP vial from refrigeration and allow to reach room temperature (15–20 minutes)

  2. 2

    Clean vial top with alcohol swab and allow to air dry completely

  3. 3

    Using a sterile syringe, draw the calculated volume of bacteriostatic water (BAC water)

  4. 4

    Inject BAC water slowly down the side of the vial — do not aim directly at the powder

  5. 5

    Gently swirl in circular motions — DO NOT shake vigorously as this degrades the peptide

  6. 6

    Allow 2–3 minutes for full dissolution — solution should be clear and colorless

  7. 7

    Draw calculated dose into an insulin syringe for subcutaneous injection

  8. 8

    Inject into abdomen, thigh, or upper arm. Rotate injection sites to prevent lipodystrophy

  9. 9

    Store reconstituted solution refrigerated (2–8°C) and use within 28 days

What to Expect

Week 1–2

Subtle mood and focus improvements may begin. Sleep quality often improves early.

Week 2–4

Increased mental clarity, word recall, and reduced brain fog reported by many.

Week 4–8

Consistent cognitive improvements. Better stress response and working memory.

Week 8+

Sustained cognitive and neurological benefits. Effects may persist post-cycle.

Side Effects & Safety

  • Headache, particularly at initiation
  • Mild anxiety or restlessness with some compounds
  • Nasal irritation (intranasal administration)
  • Sleep disturbance if dosed too close to bedtime
  • Rare: Mood changes or emotional lability

FDA Status & Regulatory Info

Research Only

Delta sleep-inducing peptide (DSIP) is a nonapeptide first isolated in 1977 from thalamic perfusate of sleeping rabbits by Monnier et al. that induced slow-wave (delta) sleep when infused. Subsequent research has explored roles in pain modulation, stress response, temperature regulation, and antioxidant effects. Clinical evidence is limited and inconsistent; mechanism remains poorly characterized. Research only.

Rx Required: No
503A Ban: No
Telehealth: N/A
Full FDA Status Tracker

Frequently Asked Questions

Community-reported data

The information below reflects self-reported experiences from PeptIQ app users. It is not clinical evidence and should not replace professional medical advice.

What 1,830 users report

Observational self-reports (modeled when live data is unavailable). Not clinical outcomes.

1830 community reports

Overall experience

From check-in ratings — separate from side effects logged below. Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.

Favorable 54% · Mixed 32% · Unfavorable overall 14%

Most reported benefits

Benefits users selected when logging a favorable or mixed check-in.

Joint comfort
177
Recovery
167
Digestive comfort
143
Skin appearance
50
Appetite control
106

Most logged side effects

Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.

Injection site reaction
93
Anxiety
67
Flushing
108
Headache
46
GI discomfort
106

Self-reported dose per injection

Median bucket: 0.6–1 mg · Most common: 0.4–0.6 mg

Reports span 0.05–5 mg

0.05–0.1 mg
7
0.1–0.2 mg
16
0.2–0.4 mg
24
0.4–0.6 mg
27
0.6–1 mg
18
1–2 mg
15
2–3 mg
10
3–5 mg
4

Anonymized self-reports from PeptIQ users — not prescribing guidance. Buckets group similar logged amounts; open-ended top buckets mean “at least” that dose.

Common discussion topics

timing34stacking42side effects20dsip13

How repeat users are trending

Among repeat reporters, 64% said they felt similar to their last entry, 34% more positive, and 14% more negative.

Overall, repeat reporters leaned more positive than their previous entry.

Median gap between entries: 32 days · Based on 403 repeat reporters

Share Your Experience

Rate DSIP in the PeptIQ app and help the community make informed decisions.

Research References (5)

Cited PubMed, trial registry, and label sources for education only. We do not control third-party content.

  1. PubMed

    Delta-sleep-inducing peptide (DSIP): a review

    Graf MV, Kastin AJ. Neuroscience and biobehavioral reviews. 1984

    Source
    Wiki study page →

Wiki tools

Observational indexes and compare views for DSIP.

Educational information only

This page is for educational reference. It is not medical or legal advice. PeptIQ does not sell peptides or list vendors. Consult the FDA and a licensed healthcare professional for current regulations and individualized guidance.

PeptIQ app

Log your DSIP protocol in PeptIQ

Turn this DSIP guide into a living protocol — doses, vials, and history in one place.

Track DSIPOpen web app

iOS, Android, and web

Ask PeptIQ

Two taps on our guided quiz, then keep going in iMessage with sources — not Instagram screenshots.

Start the quizOr try Peptide X Quiz →

Quick Facts

Half-Life
~30 minutes
Target
Sigma receptors, hypothalamic-pituitary axis, thalamic sleep centers
Route
Injectable
Availability
Research only
Rx Required
No
503A Ban
No
Browse peptide education

Talk with a clinician

PeptIQ is education only. We do not sell peptides or list vendors. Discuss DSIP with a licensed healthcare provider — not medical advice, not a prescription.

Download PeptIQ

Wiki tools

Observational indexes and compare views for DSIP.